INGN moved above its 50-day moving average on October 01, 2026 date and that indicates a change from a downward trend to an upward trend. In 37 of 50 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 74%.
The Momentum Indicator moved above the 0 level on September 24, 2026. You may want to consider a long position or call options on INGN as a result. In 62 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 70%.
The 10-day moving average for INGN crossed bullishly above the 50-day moving average on October 08, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 61%.
Following a +6.45% 3-day Advance, the price is estimated to grow further. Considering data from situations where INGN advanced for three days, in 188 of 266 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
The Aroon Indicator entered an Uptrend today. In 115 of 169 cases where INGN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 68%.
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where INGN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
INGN broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. INGN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 57 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 60 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.078) is normal, around the industry mean (2.914). P/E Ratio (-7.802) is within average values for comparable stocks, (1.904). Projected Growth (PEG Ratio) (1.290) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (0.393) is also within normal values, averaging (40.124).
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
OSUR moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend. In 30 of 40 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 75%.
The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on OSUR as a result. In 64 of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 70%.
The Moving Average Convergence Divergence (MACD) for OSUR just turned positive on October 23, 2026. Looking at past instances where OSUR's MACD turned positive, the stock continued to rise in 29 of 44 cases over the following month. The odds of a continued upward trend are 66%.
The 10-day moving average for OSUR crossed bullishly above the 50-day moving average on September 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 69%.
Following a +4.89% 3-day Advance, the price is estimated to grow further. Considering data from situations where OSUR advanced for three days, in 175 of 254 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.
The Aroon Indicator entered an Uptrend today. In 101 of 138 cases where OSUR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 73%.
The 10-day RSI Indicator for OSUR moved out of overbought territory on October 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 21 similar instances where the indicator moved out of overbought territory. In 17 of the 21 cases, the stock moved lower in the following days. This puts the odds of a move lower at 81%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where OSUR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
OSUR broke above its upper Bollinger Band on October 23, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of 40 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.896) is normal, around the industry mean (4.994). P/E Ratio (-5.986) is within average values for comparable stocks, (37.175). Projected Growth (PEG Ratio) (0.390) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (2.195) is also within normal values, averaging (56.876).
The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. OSUR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 52 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OSUR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
INGN | OSUR | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 37 | 36 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 60 Fair valued | 40 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 94 | 94 | |
PRICE GROWTH RATING 1..100 | 39 | 46 | |
P/E GROWTH RATING 1..100 | 57 | 52 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
OSUR's Valuation (40) in the Medical Specialties industry is in the same range as INGN (60). This means that OSUR’s stock grew similarly to INGN’s over the last 12 months.
OSUR's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as INGN (100). This means that OSUR’s stock grew similarly to INGN’s over the last 12 months.
OSUR's SMR Rating (94) in the Medical Specialties industry is in the same range as INGN (94). This means that OSUR’s stock grew similarly to INGN’s over the last 12 months.
INGN's Price Growth Rating (39) in the Medical Specialties industry is in the same range as OSUR (46). This means that INGN’s stock grew similarly to OSUR’s over the last 12 months.
OSUR's P/E Growth Rating (52) in the Medical Specialties industry is in the same range as INGN (57). This means that OSUR’s stock grew similarly to INGN’s over the last 12 months.
| INGN | OSUR | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 90% | 1 day ago 81% |
| Stochastic ODDS (%) | 1 day ago 81% | 1 day ago 77% |
| Momentum ODDS (%) | 1 day ago 70% | 1 day ago 70% |
| MACD ODDS (%) | N/A | 1 day ago 66% |
| TrendWeek ODDS (%) | 1 day ago 74% | 1 day ago 72% |
| TrendMonth ODDS (%) | 1 day ago 73% | 1 day ago 75% |
| Advances ODDS (%) | 1 day ago 71% | 3 days ago 69% |
| Declines ODDS (%) | 10 days ago 82% | 10 days ago 80% |
| BollingerBands ODDS (%) | 1 day ago 90% | 1 day ago 79% |
| Aroon ODDS (%) | 1 day ago 68% | 1 day ago 73% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
INGN’s FA Score shows that 0 FA rating(s) are green while OSUR’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
INGN’s TA Score shows that 5 TA indicator(s) are bullish while OSUR’s TA Score has 6 bullish TA indicator(s).
INGN (@Medical/Nursing Services) experienced а +13.60% price change this week, while OSUR (@Pharmaceuticals: Other) price change was +14.40% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.51%. For the same industry, the average monthly price growth was -9.72%, and the average quarterly price growth was -10.64%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.78%. For the same industry, the average monthly price growth was -3.41%, and the average quarterly price growth was +7.38%.
INGN is expected to report earnings on Nov 05, 2026.
OSUR is expected to report earnings on Nov 04, 2026.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Pharmaceuticals: Other (+2.78% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
A.I.dvisor indicates that over the last year, INGN has been loosely correlated with VCYT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if INGN jumps, then VCYT could also see price increases.
| Ticker / NAME | Correlation To INGN | 1D Price Change % | ||
|---|---|---|---|---|
| INGN | 100% | +0.85% | ||
| VCYT - INGN | 46% Loosely correlated | +4.11% | ||
| STRRP - INGN | 44% Loosely correlated | -1.64% | ||
| OSUR - INGN | 39% Loosely correlated | +8.68% | ||
| IRTC - INGN | 39% Loosely correlated | +1.36% | ||
| ENOV - INGN | 37% Loosely correlated | -2.36% | ||
More | ||||
A.I.dvisor indicates that over the last year, OSUR has been loosely correlated with IQV. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if OSUR jumps, then IQV could also see price increases.
| Ticker / NAME | Correlation To OSUR | 1D Price Change % | ||
|---|---|---|---|---|
| OSUR | 100% | +8.68% | ||
| IQV - OSUR | 43% Loosely correlated | +0.37% | ||
| MTD - OSUR | 42% Loosely correlated | -0.85% | ||
| RVTY - OSUR | 41% Loosely correlated | +0.94% | ||
| IART - OSUR | 41% Loosely correlated | -3.37% | ||
| INGN - OSUR | 38% Loosely correlated | +0.85% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SCIO | 20.08 | 0.05 | +0.25% |
| First Trust Structured Credit Income Opportunities ETF (SCIO) | |||
| DGAP | 31.24 | 0.02 | +0.05% |
| FT Vest U.S. Equity Buffer & Digital Return ETF - April (DGAP) | |||
| GSY | 49.96 | 0.01 | +0.02% |
| Invesco Ultra Short Duration ETF (GSY) | |||
| FEBM | 31.78 | N/A | -0.02% |
| FT Vest US Equity Max Buffer ETF-February (FEBM) | |||
| XMAR | 43.67 | -0.03 | -0.07% |
| FT Vest U.S. Equity Enhance & Moderate Buffer ETF - March (XMAR) | |||